Pegylated C-peptide
US8691755B2 · kind B2 · utility
4Cited by
40References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 4, 2012 |
| Grant date | Apr 8, 2014 |
| Priority date | — |
| Expiry date | May 4, 2032 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K14/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to modified forms of C-peptide, and methods for their use. In one aspect, the modified forms of C-peptide comprise PEGylated C-peptide derivatives comprising at least one PEG group attached to the N-terminus, which exhibit superior pharmacokinetic and biological activity in vivo.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.